Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-1990 | 01-1990 | 10-1989 | 07-1989 | 04-1989 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,261 | 2,015 | 1,424 | 1,365 | 1,358 |
| TOTAL | $2,261 | $2,015 | $1,424 | $1,365 | $1,358 |
| Non-Current Assets | |||||
| PPE Net | 8,189 | 8,231 | 8,489 | 8,096 | 8,394 |
| Other Non-Current Assets | 4,979 | 4,810 | 4,786 | 4,939 | 5,072 |
| TOTAL | $13,168 | $13,041 | $13,275 | $13,035 | $13,466 |
| Total Assets | $15,429 | $15,056 | $14,699 | $14,400 | $14,824 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,377 | 4,160 | 4,782 | 3,366 | 4,947 |
| Accrued Expenses | 2,521 | 2,594 | 2,177 | 2,143 | 2,192 |
| TOTAL | $7,806 | $8,539 | $8,346 | $6,754 | $8,392 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 649 | 362 | 363 | 363 | 515 |
| TOTAL | $2,244 | $1,807 | $1,596 | $1,309 | $1,429 |
| Total Liabilities | $10,050 | $10,346 | $9,942 | $8,063 | $9,821 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 43 | 43 | 43 | 43 |
| Other shareholders' equity | -78 | -61 | -106 | -80 | -77 |
| TOTAL | $25,533 | $25,497 | $25,369 | $24,823 | $24,826 |
| Total Liabilities And Equity | $35,583 | $35,843 | $35,311 | $32,886 | $34,647 |